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Background: Mitochondrial dysfunction is involved in a number of chronic 
neurodegenerative disorders. Acetyl-L-carnitine (ALC) has been proposed to confer 
effective neuroprotection by increasing mitochondria viability, but little is known 
regarding the molecular mechanisms involved in its action. 
Aims: Here, we propose to characterize the action of ALC in mitochondria 
bioenergetics and functional integrity. To achieve this goal we have exposed PC12 cells 
to the toxic effect of methamphetamine (METH 1 and 100 µM) and pretreated cells 
with increasing doses of ALC (0.01, 0.1 and 1.0 mM)). After either 24 or 72h of 
incubation, mitochondrial membrane integrity and mitochondrial mass were assessed 
by using, respectively, Mitotracker CMXRos (2 μM) and Mitotracker Green (800 nM), 
and flow cytometry. Efficiency of glucose utilization was also assessed by incubating 
the cells with 37 kBq/mL of 18F-FDG (2-deoxy-2-[18F]fluoro-D-glucose) in a low 
glucose serum-free medium for 60 minutes.  
Results: Interestingly, although ALC by it self did not improve mitochondrial function, 
ALC (0.01mM and 0.1mM) was effective in preventing the decrease induced by a 72h 
exposure to METH (p<0.001). Regarding mitochondrial mass, ALC in higher doses, 
seems to induce a transitory increase of mitochondria mass (p<0.05). Furthermore, 
while a prolonged exposure to high levels of METH decreased mitochondria mass 
(p<0.001) pretreatment with ALC prevented this effect. Concerning the glucose 
metabolism, we observed an increment on glucose uptake 24h after treating the cells 
with ALC 0.01 mM (p<0.05). This was even more pronounced when cells were also 
exposed to METH 100 µM (p<0.01). At 72h, cells treated with ALC 1.0 mM presented a 
significant increased glucose uptake in all tested conditions. While this may partially 
 reflect increased energy use, it may also be caused by altered membrane permeability. 
Importantly, ALC dosing seems to be highly relevant in this process. 
Conclusion: Results indicate that ALC improves and protects mitochondrial functional 
in a dose and time-dependent manner. While lower concentrations seem to be 
beneficial, higher concentration may interfere with cell bioenergetics in a negative 
way. 
Relevance: Understanding the role of ALC in mitochondrial function will be a key factor 
in formulating future therapeutic uses.  
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